Source: Annual Congress 2006 - Pulmonary embolism and hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Webster, S. Archer, E. Michelakis (Edmonton, Canada). A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension. Eur Respir J 2006; 28: Suppl. 50, 384

Member's Comments

No comment yet.

Related content which might interest you: Combined utility of brain natriuretic peptide and cardiac troponine I may improve rapid triage and risk stratification in patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 509-513 Year: 2005 Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010 The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 NT-proBNP variation in stable pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020 Year: 2020 Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019 BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020 Year: 2020 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010